Investments
NCBR Investment Fund ASI S.A.
Potential Portfolio Companies
NCBR Investment Fund ASI S.A. with headquarter in Warsaw, entered into the Register of Entrepreneurs of the National Court Register under KRS number: 0000793596, Chmielna 69 St., Warsaw 00-801, correspondence address: Chmielna 69 St., Warsaw 00-801, (“NIF”) informs about the possibility of sending information about Potential Portfolio Company.
Your company is in the growth phase? Are you thinking about expansion?
Apply for funds for development!
Information can be sent by completing the form available at:
In line with the investment policy and strategy, NIF will invest in:
- Portfolio Companies selected and proposed by previously verified Partner Funds,
- Portfolio companies that independently report to the NIF and will be positively assessed by the NIF, subject to verification by the Partner Funds, and then participation in the investment of at least one of the Partner Funds.
NIF will invest in enterprises (Portfolio Companies) having the legal form of a capital company, with each Portfolio Company meeting the following criteria jointly:
- will be an enterprise emerging from the seed stage and start-up, i.e. in the expansion and growth phases,
- will commercialize the R&D&I project, i.e. undertake activities related to conducting scientific research or development works in order to introduce a specific product or service to the market or activities consisting in the implementation of a product or service resulting from scientific research or development works within the meaning of the Act of July 20, 2018 – Law on higher education and science (Journal of Laws of 2020, item 85),
- will be an enterprise belonging to the category of micro, small or medium-sized enterprises (i.e. employ less than 250 employees, have an annual turnover not exceeding EUR 50 million or an annual balance sheet total not exceeding EUR 43 million) within the meaning of Annex I to Commission Regulation (EU) No. 651 / 2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market pursuant to Art. 107 and 108 of the Treaty,
- will operate on any market for no longer than 7 years from the first commercial sale,
- will be based in Poland or other countries of the Organization for Economic Co-operation and Development (OECD),
- will be characterized by the Polish element, understood as having an enterprise by a portfolio company and conducting business in Poland,
- will be examined in terms of business prospects and investment risk and approved by the Partnership Fund.
IMAGENE.ME is a Polish biotechnology company that for several years has been setting new standards in genomic research, advanced genetic diagnostics, and personalized preventive healthcare. It offers a unique, integrated personal genomics ecosystem. Key elements include advanced DNA analysis, expert-level interpretation of results, and preventive and diagnostic support available through the IMAGENE.ME LIFE application and platform.
More about IMAGENE.ME:
Digital First AI offers services in a SaaS (software-as-a-service) model that enable the selection of marketing strategies and the creation of advertising creatives with the support of artificial intelligence, allowing for time savings and budget optimization. The company’s current solutions represent a milestone on the path toward fully autonomous marketing, in which artificial intelligence creates, runs, and optimizes online advertising campaigns without human involvement.
More about Digitalfirst.ai:
The mission of HiProMine is to provide customers—producers of livestock feed and pet food—with insect-based protein. Its innovative, proprietary technology enables industrial-scale production while maximizing the efficient use of raw materials, addressing the global challenge of sustainability.
More about HiProMine:
Saventic Health helps with streamlining clinical trials, diagnostics, and treatment pathways for rare diseases. The AI-driven technology identifies high-risk patients faster and more accurately, allowing to accelerate recruitment, reduce diagnostic delays, and improve outcomes.
More about Saventic Health:
Nethone specializes in the development and delivery of advanced cybersecurity software that leverages machine learning for user profiling (KYC) and for preventing online fraud (Anti-Fraud).
More about Nethone:
Talkie.ai offers fully automated customer service solutions designed for environments where the primary contact channel is a telephone hotline, particularly in the highly promising healthcare sector.
More about Talkie.ai:
Plenti offers a comprehensive platform that enables short- and long-term rental of the latest technology without leaving home. Customers can rent products via a mobile application available on the App Store and Google Play, as well as through a web application. The company’s offering includes, among others, laptops, mobile phones, home and garden equipment, cameras, and more.
More about Plenti:
The FindAir startup focuses on developing hardware and software for collecting data on medication use in the treatment of asthma and chronic obstructive pulmonary disease (COPD), enabling remote monitoring of patients’ health and communication with physicians.
More about FindAir:
DBR77 is a leading technology company specializing in the development of digital twins, the optimization of market solutions, and the creation of digital development roadmaps. ‘Our goal is to provide manufacturing and logistics companies with a sustainable competitive advantage through our digital solutions.’
More about DBR77:
Auxilius Pharma specializes in the development of next-generation drug formulations with clinically proven efficacy. The company focuses on enhancing the therapeutic value of well-established active pharmaceutical ingredients through advanced drug delivery technologies and the strategic development of intellectual property.
More about Auxilius Pharma:
Fly Focus specializes in the design and production of unmanned aerial vehicles for the civil, military, and law enforcement markets. The core of the team consists of experienced engineers with a broad range of skills and deep expertise in UAV systems.
More about Fly Focus:
Orthoget is bringing to market the OrthoNail hybrid intramedullary nail, equipped with a proprietary magneto-mechanical drive—an innovative medical device designed to address the needs of patients with congenital, developmental, post-traumatic, and iatrogenic conditions.
More about Orthoget:
Human Biome is a biotechnology company operating in the field of the human microbiome and the creator of a professional gut microbiota bank, with market implementation of products containing a full consortium of gut microbiota for use in humans.
‘We focus on the most critical domains of the microbiota—colonization resistance and immunological interactions.’
More about Human Biome: